
    
      In this study, the dose-response relationship between tesofensine and metoprolol will be
      examined and thus the optimal dose of metoprolol to mitigate the effects of tesofensine on HR
      will be determined. HR is the primary endpoint because in the previous studies it has been
      shown to be the most affected safety endpoint by the effects of tesofensine.
    
  